Flamel Technologies S.A. (ADR) (NASDAQ:FLML)

CAPS Rating: 5 out of 5

A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.

Recs

0
Player Avatar stallis (87.41) Submitted: 1/16/2009 12:46:53 PM : Outperform Start Price: $33.40 FLML Score: -77.40

It would be difficult for me to be more wrong about a stock than I was with this one. I got caught up in the "potential" of their technology and ignored their poor execution.

Featured Broker Partners


Advertisement